If cancer in the bladder is only found in its connective tissue or inner lining layers—and not yet in the muscle layer—it’s considered non-muscle invasive bladder cancer (NMIBC). This type of cancer can present in individuals for several reasons, including those who are older or have a family history of bladder cancer.

Verana Health’s NMIBC Qdata module was developed to help advance clinical research for bladder cancer patients. With bladder cancer being one of the most common cancer types in the United States and across the globe, it’s imperative that steps are taken to improve survival rates. Bladder cancer research can provide real-world evidence for better treatment interventions.

Through Verana Health’s partnership with the American Urological Association (AUA) Quality (AQUA)® Registry, we can analyze and curate electronic health record (EHR) data to provide exclusive insights. This can include date of diagnosis, treatment plans, T stage documentation, tumor grade, and whether there is disease recurrence. By understanding treatment patterns and patient outcomes from NMIBC real-world data, researchers and clinicians can shape future strategies for patient care.